# FASTER-Tlalpan Study in Mexico: HPV Vaccination Impact on Cervical Cancer Screening Program

> **NCT03105856** · PHASE4 · COMPLETED · sponsor: **Instituto Nacional de Salud Publica, Mexico** · enrollment: 3000 (actual)

## Conditions studied

- Cervical Intraepithelial Neoplasia
- HPV-Related Cervical Carcinoma

## Interventions

- **BIOLOGICAL:** CERVARIX
- **BIOLOGICAL:** GARDASIL

## Key facts

- **NCT ID:** NCT03105856
- **Lead sponsor:** Instituto Nacional de Salud Publica, Mexico
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-03
- **Primary completion:** 2018-12-15
- **Final completion:** 2018-12-15
- **Target enrollment:** 3000 (ACTUAL)
- **Last updated:** 2020-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03105856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03105856, "FASTER-Tlalpan Study in Mexico: HPV Vaccination Impact on Cervical Cancer Screening Program". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03105856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*